Axe Compute Inc. is a neocloud AI infrastructure company that provides dedicated, bare-metal GPU compute and large-scale AI factory build-outs. The company, formerly known as Predictive Oncology Inc. and renamed in December 2025, operates through two core offerings: Axe Compute Access, which delivers high-performance GPU capacity across global locations, and Axe Compute Build, which designs, deploys, owns, and operates dedicated AI infrastructure under multiyear, take-or-pay contracts.
Following the completed sale of its Helomics drug-discovery business in September 2026, Axe Compute is now a pure-play GPU infrastructure provider. It works with partners including NVIDIA (NVDA), Supermicro (SMCI), and Penguin Solutions (PENG), and is headquartered in Miami, Florida. Investors follow the stock for its exposure to surging AI compute demand, its contract-driven revenue model, and its rapid but capital-intensive growth. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Over the last 30 days, AGPU declined approximately 34%, falling from a closing price near $8.79 to around $5.80. The move was not linear: shares briefly rebounded above $8.80 in early November before sliding again into the middle of the month.
The longer view shows a deeper unwind. About three months ago, in mid-August, the stock traded near $10.69; at current levels that represents a decline of roughly 46%. After peaking at $13.49 in late September, AGPU has steadily given back gains, with the most pronounced selling occurring in mid-October and again in early November. The stock's 52-week range of $1.03 to $13.49 underscores how volatile the name has been over the past year.
The 30-day decline is best understood as a continuation of a retracement from the late-September peak rather than the result of a single adverse event. Several verifiable factors have contributed to the pressure. AGPU is a small-cap stock with a limited float, institutional ownership of only about 7.4%, and a beta near 3.8, making it prone to outsized swings in either direction.
The company released third-quarter 2026 results in mid-November, reporting revenue of $7.2 million, up 125% sequentially, and net income of $11.5 million, or $0.52 per diluted share. However, a substantial portion of that income came from $15.0 million in largely non-cash fair-value gains on digital assets and securities received in the Helomics sale, and much of the contracted revenue backlog has yet to begin flowing through the income statement. Shares traded lower following the report, consistent with the stock's pattern of elevated volatility around news events.
Dilution has also weighed on the share count, which has grown roughly 412% over the past year, and the company has continued to issue equity-based compensation and inducement grants. These factors, combined with a broad retracement in speculative, high-multiple growth names, help explain the recent weakness.
Over the trailing quarter, AGPU has shifted from a momentum-driven rally into a sustained correction. In August and September, shares surged on enthusiasm around the company's pivot to AI infrastructure and a series of large contract announcements, ultimately reaching $13.49. Since then, the narrative has shifted toward execution and financing concerns.
During the quarter, Axe Compute signed more than $2.8 billion in new Build contracts, bringing total contract value above $3 billion, acquired its first wholly owned cluster of 2,304 NVIDIA B300 GPUs for $124.4 million, and completed the Helomics divestiture to become a pure-play neocloud. Despite these milestones, the market has focused on the gap between contracted backlog and current revenue, the heavy capital requirements of deploying clusters, and the expanding share count. The result has been a meaningful repricing of the stock from its peak.
Looking ahead, the key factors to monitor include the timing and pace at which signed Build contracts convert into recognized revenue as clusters are deployed and placed in service. Customer acceptance of the Georgia cluster, expected in the fourth quarter of 2026, is a near-term operational milestone. Investors should also watch capital deployment and financing for the multi-billion-dollar contract backlog, any further equity issuance and its dilutive effect, and gross-margin trends as owned clusters come online.
Broader drivers include demand for AI infrastructure, the supply and pricing of NVIDIA GPUs, and the competitive dynamics of the neocloud sector. Macroeconomic conditions and risk appetite for speculative, high-beta growth equities are likely to remain important given AGPU's volatility profile. As with any early-stage, capital-intensive business, execution risk and the pace of backlog monetization will be central to how the stock trades from current levels. From what I see, using Tickeron’s AI Trend Prediction Engine can help track some of these momentum shifts.
In my own workflow, I turn to Tickeron’s AI Trading Bots when evaluating volatile names like this one. The platform offers a range of automated strategies across different timeframes, which helps me compare systematic approaches against the specific drivers I’m watching for AGPU without having to build custom models from scratch. It’s a practical way to add another layer of perspective to the fundamental and technical analysis.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for AGPU crossed bearishly below the 50-day moving average on October 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for AGPU turned negative on November 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 36 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AGPU declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for AGPU entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AGPU's RSI Oscillator exited the oversold zone, 39 of 43 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Momentum Indicator moved above the 0 level on November 19, 2026. You may want to consider a long position or call options on AGPU as a result. In 75 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.
Following a +17.87% 3-day Advance, the price is estimated to grow further. Considering data from situations where AGPU advanced for three days, in 193 of 236 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
AGPU may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 21 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 43 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.291) is normal, around the industry mean (16.188). P/E Ratio (-1.024) is within average values for comparable stocks, (45.064). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.427) among similar stocks. P/S Ratio (86.957) is also within normal values, averaging (103.301).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. AGPU’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 70 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AGPU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a company, which engages in the manufacture and distribution of healthcare products, and provision of related services.
Industry ComputerCommunications